-
3 Research-Driven Contract Manufacturer, Over-the-Counter Formulations Exporter and Point-of-Care Molecular Diagnostics Maker Stocks With a Strong Future Roadmap: Anthem Biosciences, Marksans Pharma and Molbio Diagnostics
- October 26, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
No Comments
CDMO, OTC Pharma and Diagnostics Stocks with a strong future roadmap: Anthem Biosciences, Marksans Pharma and Molbio Diagnostics. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Active Ingredients and Custom Manufacturing, Biologics and Formulations and Research-Led CDMO Stocks With a Strong Future Roadmap: Neuland Laboratories, Shilpa Medicare and Anthem Biosciences
- October 23, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Contract Manufacturing and API Innovator Stocks with a strong future roadmap: Neuland Laboratories, Shilpa Medicare and Anthem Biosciences. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.
-
3 Chronic Therapy Brands, Biotech Development Services and Ingredients and Formulations Stocks With a Strong Future Roadmap: Eris Lifesciences, Anthem Biosciences and Laurus Labs
- October 22, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Domestic Brand and Biotech Outsourcing Stocks with a strong future roadmap: Eris Lifesciences, Anthem Biosciences and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Branded Formulations, Custom Synthesis and Research-Led CDMO Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Divi’s Laboratories and Anthem Biosciences
- October 21, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Pharma Manufacturing and Research Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Divi’s Laboratories and Anthem Biosciences. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Oral Generics, Biotech Research Services and Fermentation APIs Stocks With a Strong Future Roadmap: Strides Pharma Science, Anthem Biosciences and Concord Biotech
- October 21, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Biotech and Generics Stocks with a strong future roadmap: Strides Pharma Science, Anthem Biosciences and Concord Biotech. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Pharma Ingredient Stocks With a Strong Future Roadmap: Acutaas Chemicals, Sudeep Pharma and Anthem Biosciences
- October 7, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Acutaas Chemicals, Sudeep Pharma and Anthem Biosciences compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.